No evidence for increased oxidative damage to lipids, proteins, or DNA in Huntington's disease

被引:39
作者
Alam, ZI
Halliwell, B
Jenner, P
机构
[1] Kings Coll London, GKT Sch Biomed Sci, Neurodegenerat Dis Res Ctr, Wolfson Ctr Age Related Dis, London SE 1UL, England
[2] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore
关键词
Huntington's disease; oxidative damage; lipids; proteins; DNA;
D O I
10.1046/j.1471-4159.2000.0750840.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It has been proposed that mitochondrial dysfunction and excitotoxic mechanisms lead to oxidative damage in the brain of Huntington's disease patients. We sought evidence that increased oxidative damage occurs by examining postmortem brain material from patients who had died with clinically and pathologically diagnosed Huntington's disease. Oxidative damage was measured using methods that have already demonstrated the presence of increased oxidative damage in Parkinson's disease, Alzheimer's disease, and senile dementia of the Lewy body type. No alterations in the levels of lipid peroxidation (as measured by lipid peroxides and thiobarbituric acid-malondialdehyde adducts) were found in the caudate nucleus, putamen, or frontal cortex of patients with Huntington's disease compared with normal controls. Similarly, there were no elevations in the levels of 8-hydroxyguanine or of a wide range of other markers of oxidative DNA damage. Levels of protein carbonyls in these tissues were also unaltered. Our data suggest that oxidative stress is not a major component of the degenerative processes occurring in Huntington's disease, or at least not to the extent that occurs in other neurodegenerative disorders.
引用
收藏
页码:840 / 846
页数:7
相关论文
共 34 条
  • [1] Alam ZI, 1997, J NEUROCHEM, V69, P1326
  • [2] Oxidative DNA damage in the parkinsonian brain: An apparent selective increase in 8-hydroxyguanine levels in substantia nigra
    Alam, ZI
    Jenner, A
    Daniel, SE
    Lees, AJ
    Cairns, N
    Marsden, CD
    Jenner, P
    Halliwell, B
    [J]. JOURNAL OF NEUROCHEMISTRY, 1997, 69 (03) : 1196 - 1203
  • [3] Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia
    Browne, SE
    Bowling, AC
    MacGarvey, U
    Baik, MJ
    Berger, SC
    Muqit, MMK
    Bird, ED
    Beal, MF
    [J]. ANNALS OF NEUROLOGY, 1997, 41 (05) : 646 - 653
  • [4] Browne SE, 1999, BRAIN PATHOL, V9, P147
  • [5] BASAL LIPID-PEROXIDATION IN SUBSTANTIA NIGRA IS INCREASED IN PARKINSONS-DISEASE
    DEXTER, DT
    CARTER, CJ
    WELLS, FR
    JAVOYAGID, F
    AGID, Y
    LEES, A
    JENNER, P
    MARSDEN, CD
    [J]. JOURNAL OF NEUROCHEMISTRY, 1989, 52 (02) : 381 - 389
  • [6] Astrocyte-enhanced neuronal survival is mediated by scavenging of extracellular reactive oxygen species
    Drukarch, B
    Schepens, E
    Stoof, JC
    Langeveld, CH
    Van Muiswinkel, FL
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 1998, 25 (02) : 217 - 220
  • [7] EXCITOTOXIN LESIONS IN PRIMATES AS A MODEL FOR HUNTINGTONS-DISEASE - HISTOPATHOLOGIC AND NEUROCHEMICAL CHARACTERIZATION
    FERRANTE, RJ
    KOWALL, NW
    CIPOLLONI, PB
    STOREY, E
    BEAL, MF
    [J]. EXPERIMENTAL NEUROLOGY, 1993, 119 (01) : 46 - 71
  • [8] Mitochondria in neurodegeneration: Acute ischemia and chronic neurodegenerative diseases
    Fiskum, G
    Murphy, AN
    Beal, MF
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1999, 19 (04) : 351 - 369
  • [9] INHIBITION OF SUCCINATE-DEHYDROGENASE BY MALONIC-ACID PRODUCES AN EXCITOTOXIC LESION IN RAT STRIATUM
    GREENE, JG
    PORTER, RHP
    ELLER, RV
    GREENAMYRE, JT
    [J]. JOURNAL OF NEUROCHEMISTRY, 1993, 61 (03) : 1151 - 1154
  • [10] Mitochondrial defect in Huntington's disease on caudate nucleus
    Gu, M
    Gash, MT
    Mann, VM
    JavoyAgid, F
    Cooper, JM
    Schapira, AHV
    [J]. ANNALS OF NEUROLOGY, 1996, 39 (03) : 385 - 389